CHROChromocell Therapeutics Corp

NYSE chromocell.com


$ 1.31 $ -0.11 (-7.75 %)    

Monday, 10-Jun-2024 15:59:00 EDT
QQQ $ 464.61 $ 1.87 (0.4 %)
DIA $ 389.34 $ 0.80 (0.21 %)
SPY $ 535.72 $ 1.65 (0.31 %)
TLT $ 90.89 $ -0.61 (-0.67 %)
GLD $ 213.56 $ 1.94 (0.92 %)
$ 1.31
$ 1.44
$ 0.00 x 0
$ 0.00 x 0
$ 1.31 - $ 1.44
$ 1.21 - $ 6.00
18,031
na
7.55M
$ 1.77
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-16-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-travelers-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

 why-invo-bioscience-shares-are-trading-higher-by-around-73-here-are-20-stocks-moving-premarket

Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.

Core News & Articles

Dear Fellow Stockholders,With my inaugural letter to stockholders, I am pleased to provide an update on our recent initial publ...

Core News & Articles

Chromocell Therapeutics Corp. ("Chromocell", or the "Company"), (NYSE:CHRO), a pioneer in the development of no...

Core News & Articles

Benuvia Operations, LLC ("Benuvia"), a leader in pharmaceutical innovation, and Chromocell Therapeutics Corp. ("Chr...

Core News & Articles

Chromocell Therapeutics Corporation (NYSE:CHRO) ("Chromocell" or the "Company"), a clinical-stage biotech compa...